approved O-1

Assistant Professor

Rheumatology · Canada · 2025-05-02

Processing Time
11 days
Decision Date
2025-05-02
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

4 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 12 publications, including 4 peer-reviewed journal articles and 8 conference abstracts in the field of rheumatology.

Original Contributions (Met)

Her research led to safer clinical treatment pathways for IBD and faster identification of GCA, reducing risks of permanent complications like vision loss.

Judging the Work of Others (Met)

The petitioner completed 7 verified peer reviews for prestigious publications including the Journal of Clinical Rheumatology.

Critical Employment Role (Met)

As an Assistant Professor, she leads clinical and academic efforts focused on diagnostic and treatment innovations in autoimmune diseases.

Why This Petition Was Approved

The approval was based on the petitioner's original contributions to rheumatology, specifically in improving diagnostic screening for scleroderma and GCA. Her publication record and high citation count from international experts demonstrated sustained national and international acclaim. Additionally, her role as an Assistant Professor was deemed a position of critical importance to the scientific and medical community.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Conference Presentations
Judging Experience
Original Contributions
Achievements
  • Published 12 total works, including 4 peer-reviewed journal articles and 8 conference abstracts
  • Accumulated 85 total citations with an article in the top 10% most cited in Clinical Medicine for its year
  • Completed 7 verified peer reviews for the International Journal of Rheumatic Diseases and the Journal of Clinical Rheumatology
  • Developed clinical treatment pathways for IBD and screening protocols for scleroderma and GCA
  • Research cited by international experts from Switzerland, UK, Netherlands, Australia, India, and Colombia

Similar Cases

Scientist

Biotechnology · China

WeGreened O-1 approved
California 17 days 2025-06-28
The approval was based on the petitioner's record of 5 peer-reviewed journal articles and 10 scientific abstracts which garnered 36 citations. Additionally, her participation as a peer reviewer for reputable journals and the funding of her research by major agencies like the NSF, NIH, and NASA satisfied the O-1A criteria. The strategic use of premium processing led to an RFE-free decision in 17 days.

Robotics Engineer

Robotics · China

WeGreened O-1 approved
Florida 11 days 2025-03-14
The approval was based on the petitioner's record of 5 peer-reviewed journal articles and 2 preprints in highly ranked journals. He demonstrated sustained acclaim through 54 citations, including a paper in the top 10% of its field, and 12 completed peer reviews for prestigious venues. Additionally, the petition showed major research funding and significant contributions to drug sensitivity prediction and robotic navigation.

Physician

Healthcare · Canada

WeGreened O-1 approved
11 days 2025-05-30
The approval was based on a strong scholarly record including 24 peer-reviewed articles and nearly 1,000 citations. Evidence of competitive funding from international bodies like the CIHR, SNSF, ERC, and BBSRC demonstrated global recognition. Her role in developing novel AI-assisted disease detection methods satisfied the criteria for original contributions of major significance.

Scientist

Biotechnology · China

WeGreened O-1 rfe approved
Maryland 216 days 2025-07-08
The petition satisfied the O-1A criteria through 19 peer-reviewed publications in top journals like PNAS and Cell Reports, and a record of 89 verified journal reviews. Evidence showed the petitioner's work falls within the top 10% of most-cited studies in immunology.

Frequently Asked Questions

A approved O-1 (I-129) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 11 days
Criteria Met 4 / 3
Evidence Types 7

O-1 Case Data

Scraped Case Data

Total Cases 83
Success Rate 68.7%
Sustained 57
Dismissed 26

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist